Online advertising for prescription weight loss drugs might be against the law, Australia's medicine regulator says.
Websites advertising prescriptions for weight loss drugs via an online quiz could find themselves in hot water from Australia's medicine regulator.
The quiz is then checked by a doctor, the user receives an email about whether they have been successful and the weight loss injectable drug Saxenda is mailed to their home.The Therapeutic Goods Administration on Tuesday stopped short of confirming it was investigating the legality of websites like Juniper and Mosh advertising the medicine.
The injectable medication is taken once a day and works by making individuals feel fuller and less hungry.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Why more than a million people are flocking to this one Sydney suburbLakemba’s Haldon Street has transformed into 'Ramadan Nights' for the next month; a Middle Eastern and south-east Asian food bazaar with more than 70 stalls. Here are five things to try.
Read more »
Stretching his 15 minutes of fame: why Andy Warhol still has the power to inspireThe array of new exhibitions, plays and books shows the maverick artist has struck a chord with the digital generation
Read more »
Why don’t companies pay employees’ student loans, asks David LloydLet’s find ways to ensure everyone gets to go to university if they want to, and stay on to graduate, says a leading vice-chancellor.
Read more »
Why automatic indexing of the $3m super cap is a bad ideaTaxing unrealised gains and increases to the total super balance are just two of many challenges to the proposed government change.
Read more »
Why bankers are bracing for more private equity failuresLeading bankers predict that an increasing number of private equity groups will abandon loss-making assets, following last month’s collapse of Scott’s Refrigerated Logistics, writes Karen Maley.
Read more »
Why the writing was on the wall for the Swiss banking sectorSwiss bankers kept subsidising high-risk investment banking products with their consumer business. And the authorities let them do it, writes Adrian Blundell-Wignall.
Read more »